Effect of Curcuminoid on Methadone Use Disorder: A Randomized Retrospective Trial

نویسندگان

1 دانشگاه تربیت مدرس

2 دانشگاه شهید بهشتی

3 دانشگاه علم و صنعت ایران

4 دانشگاه علوم انتظامی امین

5

6 دانشگاه سمنان

doi
10.48307/iahsj.2024.444695.1148
چکیده

Objectives : Methadone maintenance treatment (MMT), as a common therapy for opioid dependence, is associated with certain adverse effects. This trial examined the effects of curcuminoid supplementation on depression, anxiety, sleep quality, and metabolic parameters in MMT patients. Methods : This clinical trial enrolled 60 eligible participants aged 18 to 60 years, of whom 47 completed the study. Subjects were randomly assigned to either an intervention (daily curcuminoid capsules) or a control (daily placebo) group for 12 weeks. Demographic data were collected initially. Primary outcomes (depression [BDI], anxiety [BAI], sleep quality [PSQI]) were assessed at baseline and week 12. Fasting blood samples (10ml) were obtained at these timepoints to analyze secondary outcomes (glucose, lipid profile, oxidative stress markers [MDA, NO], and inflammatory factors [hs-CRP]). Results : No significant differences emerged in BDI (P=0.83), BAI (P=0.67), or PSQI (P=0.96) scores between groups at week 12. However, the curcuminoid group showed significant reductions in NO (P=0.001), hs-CRP (P=0.01), MDA (P=0.004), and fasting glucose (P=0.03). Lipid parameters (TG, VLDL-C, HDL-C, total cholesterol, LDL-C) and antioxidant markers (TAC, GSH) remained unchanged (all P>0.05). Conclusion : Curcuminoid supplementation significantly decreased NO, hs-CRP, MDA, and fasting glucose levels in MMT patients, suggesting potential benefits for mitigating certain metabolic complications of methadone therapy. Further research is warranted to confirm these findings.